EUTM file information

018524013

Wellixx


July 27, 2021

Trademark Summary

The trademark Wellixx was filed by BC Hilamax Oy, a corporation established under the laws of the Republic of Finland (the "Applicant"). The application was published for oppositions on August 11, 2021, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on November 11, 2021 by Dirk Rossmann GmbH on Likelihood of confusion. the opponent was represented by HORAK. RECHTSANWÄLTE PARTNERSCHAFT MBB and its proceedings were handled in English The second opposition filed on November 9, 2021 by Welly Health PBC on Likelihood of confusion. the opponent was represented by BAKER & MCKENZIE and its proceedings were handled in English

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).

Change of name and professional address of the trademark registration was recorded on October 17, 2022.

The Appeal with reference B R0124/2023-4 was Other according to Article 68(1) EUTMR with decision issued on June 4, 2023 by the EUIPO. The Opposition with reference B 003158067 was refused according to Article 8(1)(b) EUTMR with decision issued on September 12, 2024 by the EUIPO. The Opposition with reference B 003158216 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on November 16, 2022 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Diagnostic preparations for medical and veterinary use
    2. Stem cells for medical purposes
    3. Transdermal patches for medical treatment
    4. Injectable dermal fillers
    5. Antiseptic liquid bandages
    6. Surgical dressings
    7. Human vaccine preparations.